A detailed history of Dantai Capital LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Dantai Capital LTD holds 27,600 shares of NVO stock, worth $2.83 Million. This represents 4.43% of its overall portfolio holdings.

Number of Shares
27,600
Previous 27,600 -0.0%
Holding current value
$2.83 Million
Previous $3.54 Billion 11.17%
% of portfolio
4.43%
Previous 4.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $596,904 - $717,060
6,800 Added 32.69%
27,600 $2.86 Billion
Q3 2023

Nov 07, 2023

BUY
$90.94 - $199.54 $1.53 Million - $3.35 Million
16,800 Added 420.0%
20,800 $1.89 Billion
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $623,920 - $690,600
4,000 New
4,000 $647 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dantai Capital LTD Portfolio

Follow Dantai Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dantai Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dantai Capital LTD with notifications on news.